Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 132

1.

Circulating serum microRNA (miR-367-3p, miR-371a-3p, miR-372-3p, miR-373-3p) as biomarkers for patients with testicular germ cell cancers.

Syring I, Bartels J, Holdenrieder S, Kristiansen G, Müller SC, Ellinger J.

J Urol. 2014 Jul 18. pii: S0022-5347(14)03957-3. doi: 10.1016/j.juro.2014.07.010. [Epub ahead of print]

PMID:
25046619
[PubMed - as supplied by publisher]
2.

KDM5C Is Overexpressed in Prostate Cancer and Is a Prognostic Marker for Prostate-Specific Antigen-Relapse Following Radical Prostatectomy.

Stein J, Majores M, Rohde M, Lim S, Schneider S, Krappe E, Ellinger J, Dietel M, Stephan C, Jung K, Perner S, Kristiansen G, Kirfel J.

Am J Pathol. 2014 Jul 9. pii: S0002-9440(14)00326-5. doi: 10.1016/j.ajpath.2014.05.022. [Epub ahead of print]

PMID:
25016185
[PubMed - as supplied by publisher]
3.

Analysis of strains lacking known osmolyte accumulation mechanisms reveals contributions of osmolytes and transporters to abiotic stress protection.

Murdock L, Burke T, Coumoundouros C, Culham DE, Deutch CE, Ellinger J, Kerr CH, Plater SM, To E, Wright G, Wood JM.

Appl Environ Microbiol. 2014 Jun 20. pii: AEM.01138-14. [Epub ahead of print]

PMID:
24951793
[PubMed - as supplied by publisher]
4.

Nucleic acid-based tissue biomarkers of urologic malignancies.

Dietrich D, Meller S, Uhl B, Ralla B, Stephan C, Jung K, Ellinger J, Kristiansen G.

Crit Rev Clin Lab Sci. 2014 Aug;51(4):173-99. doi: 10.3109/10408363.2014.906130. Epub 2014 May 30.

PMID:
24878394
[PubMed - in process]
5.

MicroRNAs: A Novel Non-Invasive Biomarker for Patients with Urological Malignancies.

Ellinger J, Muller SC.

Curr Pharm Biotechnol. 2014 May 19. [Epub ahead of print]

PMID:
24846060
[PubMed - as supplied by publisher]
6.

Alterations of Global Histone H3K9 and H3K27 Methylation Levels in Bladder Cancer.

Ellinger J, Bachmann A, Göke F, Behbahani TE, Baumann C, Heukamp LC, Rogenhofer S, Müller SC.

Urol Int. 2014;93(1):113-8. doi: 10.1159/000355467. Epub 2014 Feb 18.

PMID:
24556868
[PubMed - in process]
7.

Serum microRNAs as biomarkers in patients undergoing prostate biopsy: results from a prospective multi-center study.

Westermann AM, Schmidt D, Holdenrieder S, Moritz R, Semjonow A, Schmidt M, Kristiansen G, Müller SC, Ellinger J.

Anticancer Res. 2014 Feb;34(2):665-9.

PMID:
24510997
[PubMed - indexed for MEDLINE]
8.

DNA hypermethylation as a predictor of PSA recurrence in patients with low- and intermediate-grade prostate cancer.

Moritz R, Ellinger J, Nuhn P, Haese A, Müller SC, Graefen M, Schlomm T, Bastian PJ.

Anticancer Res. 2013 Dec;33(12):5249-54.

PMID:
24324057
[PubMed - indexed for MEDLINE]
9.

Databases and Software for NMR-Based Metabolomics.

Ellinger JJ, Chylla RA, Ulrich EL, Markley JL.

Curr Metabolomics. 2013;1(1). doi: 10.2174/2213235X11301010028.

PMID:
24260723
[PubMed]
Free PMC Article
10.

Serum DNA hypermethylation in patients with kidney cancer: results of a prospective study.

Hauser S, Zahalka T, Fechner G, Müller SC, Ellinger J.

Anticancer Res. 2013 Oct;33(10):4651-6.

PMID:
24123044
[PubMed - indexed for MEDLINE]
11.

Prognostic significance of venous tumour thrombus consistency in patients with renal cell carcinoma (RCC).

Weiss VL, Braun M, Perner S, Harz A, Vorreuther R, Kristiansen G, Müller SC, Ellinger J.

BJU Int. 2014 Feb;113(2):209-17. doi: 10.1111/bju.12322. Epub 2013 Dec 2.

PMID:
24053185
[PubMed - indexed for MEDLINE]
12.

Diagnostic meaning of urodynamic studies in pouch incontinence: results of a small series.

Latz S, Achterberg M, Ellinger J, Engels T, Hauser S, Rogenhofer S, Müller SC, Fechner G.

Urol Int. 2014;92(2):237-41. doi: 10.1159/000353417. Epub 2013 Sep 13.

PMID:
24051578
[PubMed - in process]
13.

Tracing Metabolite Footsteps of Escherichia coli Along the Time Course of Recombinant Protein Expression by Two-Dimensional NMR Spectroscopy.

Chae YK, Kim SH, Ellinger JJ, Markley JL.

Bull Korean Chem Soc. 2012 Dec 20;33(12):4041-4046.

PMID:
23794775
[PubMed]
Free PMC Article
14.

Clinical and pathological nodal staging score for urothelial carcinoma of the bladder: an external validation.

Gierth M, Fritsche HM, Buchner H, May M, Aziz A, Otto W, Bolenz C, Trojan L, Hermann E, Tiemann A, Müller SC, Ellinger J, Brookman-May S, Stief CG, Tilki D, Nuhn P, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Wieland WF, Riedmiller H, Denzinger S, Bastian PJ, Burger M.

World J Urol. 2014 Apr;32(2):365-71. doi: 10.1007/s00345-013-1105-4. Epub 2013 Jun 5.

PMID:
23736527
[PubMed - in process]
15.

Epigenetic regulation of microRNA expression in renal cell carcinoma.

Schiffgen M, Schmidt DH, von Rücker A, Müller SC, Ellinger J.

Biochem Biophys Res Commun. 2013 Jun 21;436(1):79-84. doi: 10.1016/j.bbrc.2013.05.061. Epub 2013 May 22.

PMID:
23707942
[PubMed - indexed for MEDLINE]
16.

NMRbot: Python scripts enable high-throughput data collection on current Bruker BioSpin NMR spectrometers.

Clos LJ 2nd, Jofre MF, Ellinger JJ, Westler WM, Markley JL.

Metabolomics. 2013 Jun;9(3):558-563. Epub 2013 Jan 4.

PMID:
23678341
[PubMed]
Free PMC Article
17.

Serum DNA hypermethylation in patients with bladder cancer: results of a prospective multicenter study.

Hauser S, Kogej M, Fechner G, VON Pezold J, Vorreuther R, Lümmen G, Müller SC, Ellinger J.

Anticancer Res. 2013 Mar;33(3):779-84.

PMID:
23482744
[PubMed - indexed for MEDLINE]
18.

Prediction of outcome in patients with urothelial carcinoma of the bladder following radical cystectomy using artificial neural networks.

Buchner A, May M, Burger M, Bolenz C, Herrmann E, Fritsche HM, Ellinger J, Höfner T, Nuhn P, Gratzke C, Brookman-May S, Melchior S, Peter J, Moritz R, Tilki D, Gilfrich C, Roigas J, Zacharias M, Hohenfellner M, Haferkamp A, Trojan L, Wieland WF, Müller SC, Stief CG, Bastian PJ.

Eur J Surg Oncol. 2013 Apr;39(4):372-9. doi: 10.1016/j.ejso.2013.02.009.

PMID:
23465180
[PubMed - indexed for MEDLINE]
19.

Spindle cell rhabdomyosarcoma of the prostate.

Latz S, Ellinger J, Goltz D, Marx C, Leuschner I, Müller SC, Fechner G.

Int J Urol. 2013 Sep;20(9):935-7. doi: 10.1111/iju.12082. Epub 2013 Jan 16.

PMID:
23320845
[PubMed - indexed for MEDLINE]
20.

Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer?

Scheffer AR, Holdenrieder S, Kristiansen G, von Ruecker A, Müller SC, Ellinger J.

World J Urol. 2014 Apr;32(2):353-8. doi: 10.1007/s00345-012-1010-2. Epub 2012 Dec 25.

PMID:
23266581
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk